1 Bonita R.Stroke prevention:a global perspective[A].In: Norris JW, Hachinski V, eds.Stroke prevention[M].New York, NY:Oxford University Press, 2001:259-74 2 Sarhan S, Wettstein JG, Maynard KI.Delayed treatment with 5-nitro-6, 7-dichloro-1, 4-dihydro-2, 3-quinoxalinedione, a glycine site N-methyl-D-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats[J]. Neurosci Lett, 2003;347:147-50 3 Hoyte L, Barber PA, Buchan AM, Hill MD.The rise and fall of NMDA antagonists for ischemic stroke[J].Curr Mol Med, 2004;4:131-6 4 Akins PT, Atkinson RP.Glutamate AMPA receptor antagonist treatment for ischaemic stroke[J].Curr Med Res Opin, 2002; 18:S9-13 5 Kawasaki-Yatsugi S, Ichiki C, Yatsugi S, TakahashiM, Shimizu-Sasamata M, Yamaguchi T, et al.Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model[J].Neuropharmacology, 2000; 39:211-7 6 Koinig H, Vornik V, Rueda C, Zornow MH.Lubeluzole inhibits accumulation of extracellular glutamate in the hippocampus during transient global cerebral ischemia[J].Brain Res, 2001; 898:297-302 7 Mueller RN, Deyo DJ, Brantley DR, Disterhoft JF, Zornow MH.Lubeluzole and conditioned learning after cerebral ischemia[J].Exp Brain Res, 2003;152:329-34 8 Koinig H, Morimoto Y, Zornow MH.The combination of lamotrigine and mild hypothermia prevents ischemia-induced increase in hippocampal glutamate[J].J Neurosurg Anesthesiol, 2001;13:106-12 9 Caputi L, Hainsworth AH, Lavaroni F, LeachMJ, McNaughton NC, Mercuri NB, et al.Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92[J].Brain Res, 2001;919:259-68 10 Liu C, Zhou R, Sun S.Nimodipine modulates Bcl-2 and Bax mRNA expression after cerebral ischemia[J].J Huazhong Univ Sci Technolog Med Sci, 2004;24:170-2 11 Iwasaki K, Mishima K, Egashira N, Al-Khatib IH, Ishibashi D, Irie K, et al.Effect of nilvadipine on the cerebral ischemiainduced impairment of spatial memory and hippocampal apoptosis in rats[J].J Pharmacol Sci, 2003;93:188-96 12 Adachi N, Lei B, Soutani M, Arai T.Different roles of neuronal and endothelial nitric oxide synthases on ischemic nitric oxide production in gerbil striatum[J].Neurosci Lett, 2000;288: 151-4 13 Jiang MH, Kaku T, Hada J, Hayashi Y.Different effects of eNOS and nNOS inhibition on transient forebrain ischemia[J]. Brain Res, 2002;946:139-47 14 Gursoy-Ozdemir Y, Bolay H, Saribas O, Dalkara T.Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia [J].Stroke, 2000;31:1974-80 15 Imai H, Graham DI, Masayasu H, Macrae IM.Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia[J].Free Radic BiolMed, 2003;34:56-63 16 Nito C, Kamiya T, Amemiya S, Katoh K, Katayama Y.The neuroprotective effect of a free radical scavenger and mild hypothermia following transient focal ischemia in rats[J].Acta Neurochir Suppl, 2003;86:199-203 17 Lee H, Bae JH, Lee SR.Protective effect of green tea polyphenol EGGE against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils[J].J Neurosci Res, 2004;77:892-900 18 Simi A, Porsmyr-Palmertz M, Hjerten A, Ingelman-Sundberg M, Tindberg N.The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1 beta signalling but not its biosynthesis in rat cortical glial cells[J].J Neurochem, 2002;83:727-37 19 Zhang RL, ChoppM, Jiang N, Tang WX, Prostak J, Manning AM, et al.Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat[J].Stroke, 1995;26:1438-42 20 Enlimomab Acute Stroke Trial Investigators.Use of anti-ICAM-1 therapy in ischemic stroke:results of the enlimomab acute stroke trial[J].Neurology, 2001;57:1428-34 21 Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA.Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat[J].Br J Pharmacol, 2003;140:471-6 22 Zaremba J, Skrobanski P, Losy J.Tumour necrosis factor-αis increased in the cerebrospinal fluid and serum of ischemic stroke patients and correlates with the volume of evolving brain infarct[J].Biomed Pharmacother, 2001;55:258-63 23 Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al.Tumor necrosis factor-α.A mediator of focal ischemic brain injury[J].Stroke, 1997;28:1233-44 24 Nawashiro H, Martin D, Hallenbeck JM.Neuroprotective effects of TNF binding protein in focal cerebral ischemia[J]. Brain Res, 1997;778:265-71 25 Wang X, Feuerstein GZ, Xu L, Wang H, Schumacher WA, Ogletree ML, et al.Inhibition of tumor necrosis factor-alpha-Chin J Clin Pharmacol Ther converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats[J].Mol Pharmacol, 2004;65:890-6 26 Yin W, Badr AE, Mychaskiw G, Zhang JH.Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model[J].Brain Res, 2002; 926:165-71 27 Candelario-Jalil E, Alvarez D, Castaneda JM, Al-Dalain SM, Martinez-Sanchez G, Merino N, et al.The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils[J].Brain Res, 2002;927:212-5 28 Ciceri P, Rabuffetti M, Monopoli A, Nicosia S.Production of leukotrienes in a model of focal cerebral ischemia in the rat[J]. Br J Pharmacol, 2001;133:1323-9 29 Joly LM, Mucignat V, Mariani J, Plotkine M, Charriaut-Marlangue C.Caspase inhibition after neonatal ischemia in the rat brain[J].J Cereb Blood Flow Metab, 2004;24:124-31 |